Tuchinda Papapit, Chularojanamontri Leena, Sukakul Thanisorn, Thanomkitti Kanchalit, Nitayavardhana Sunatra, Jongjarearnprasert Kowit, Uthaitas Panadda, Kulthanan Kanokvalai
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
Drugs Aging. 2014 Nov;31(11):815-24. doi: 10.1007/s40266-014-0209-x.
Elderly people tend to be sicker than young people. They also take more medications, increasing the risk of adverse drug reactions (ADRs), which are one of the leading causes of morbidity and mortality in this age group. Knowledge of cutaneous ADRs from medicine use in the elderly population is limited.
The aim of this study was to investigate demographic data, causative drugs and cutaneous manifestations of ADRs in elderly patients.
A retrospective analysis was conducted involving elderly patients aged >60 years with cutaneous ADRs in the period from 2002 to 2012. We analyzed data with respect to demographic data, clinical data, outcomes, and risk factors for serious reactions.
A total of 400 patient records were included. The mean age was 73.6 years, and 53 % were women. The common reactions were maculopapular rash (65 %) and angioedema with/without urticaria (11.3 %). Antibiotics (42.8 %) and non-steroidal anti-inflammatory drugs (9.5 %) were common causative drugs. Serious cutaneous ADRs were found in 16.5 %.
Our results show that multiple underlying medical conditions, especially cerebrovascular diseases, are risk factors for serious cutaneous ADRs in elderly patients. These findings emphasize the need for awareness about cutaneous drug reactions in elderly patients.
老年人往往比年轻人更容易患病。他们服用的药物也更多,这增加了药物不良反应(ADR)的风险,而药物不良反应是该年龄组发病和死亡的主要原因之一。关于老年人群药物使用引起的皮肤ADR的知识有限。
本研究的目的是调查老年患者的人口统计学数据、引起ADR的药物和皮肤表现。
对2002年至2012年期间年龄>60岁的老年皮肤ADR患者进行回顾性分析。我们分析了有关人口统计学数据、临床数据、结局和严重反应危险因素的数据。
共纳入400份患者记录。平均年龄为73.6岁,53%为女性。常见反应为斑丘疹(65%)和伴有/不伴有荨麻疹的血管性水肿(11.3%)。抗生素(42.8%)和非甾体抗炎药(9.5%)是常见的致病药物。16.5%的患者出现严重皮肤ADR。
我们的结果表明,多种基础疾病,尤其是脑血管疾病,是老年患者严重皮肤ADR的危险因素。这些发现强调了提高对老年患者皮肤药物反应认识的必要性。